Exp Clin Endocrinol Diabetes 2001; Vol. 109(2): 75-82
DOI: 10.1055/s-2001-14826
Reviews

© Johann Ambrosius Barth

Intraadrenal mechanisms of DHEA regulation: A hypothesis for adrenopause

S. Alesci, S. R. Bornstein
  • Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health, National Institutes of Health, Bethesda, MD, USA
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
31. Dezember 2001 (online)

Summary:

Dehydroepiandrosterone (DHEA) and its sulfate metabolite DHEAS are the major androgens secreted by the human adrenal gland. The specific control of these hormones remains unclear. While ACTH is a potent stimulator of DHEA secretion, other factors both systemic and local have been involved in adrenal androgen control. Here we review the extra and intra-adrenal regulation of DHEA and propose a hypothetical model for adrenal senescence.

References

  • 1 Adams J B. Control of secretion and the function of C19-delta 5-steroids of the human adrenal gland.  Mol Cell Endocrinol. 41 1-17 1985; 
  • 2 Albertson B D, Sienkiewicz M L, Kimball D, Munabi A K, Cassorla F, Loriaux D L. New evidence for a direct effect of prolactin on rat adrenal steroidogenesis.  Endocr Res. 13 317-333 1987; 
  • 3 Aleem F A, McIntosh T. Elevated plasma levels of beta-endorphin in a group of women with polycystic ovarian disease.  Fertil Steril. 42 686-689 1984; 
  • 4 Anderson D C. The adrenal androgen-stimulating hormone does not exist.  Lancet. 2 454-456 1980; 
  • 5 Araneo B A, Woods M L, Daynes R A. Reversal of the immunosenescent phenotype by dehydroepiandrosterone: hormone treatment provides an adjuvant effect on the immunization of aged mice with recombinant hepatitis surface antigen.  J Infect Dis. 167 830-840 1993; 
  • 6 Arlt W, Callies F, van Vlijmen J C, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte H M, Allolio B. Dehydroepiandrosterone replacement in women with adrenal insufficiency.  N Engl J Med. 341 1013-1020 1999; 
  • 7 Bähr V, Mobius K, Redmann A, Oelkers W. Ascorbate and alpha-tocopherol depletion inhibit aldosterone stimulation by sodium deficiency in the guinea pig.  Endocr Res. 22 595-600 1996; 
  • 8 Baulieu E E, Robel P. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids.  Proc Natl Acad Sci. 95 4089-4091 1998; 
  • 9 Belisle S, Menard J. Adrenal androgen production in hyperprolactinemic states.  Fertil Steril. 33 396-400 1980; 
  • 10 Bornstein S R, Chrousos G P. Clinical review 104: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs.  J Clin Endocrinol Metab. 84 1729-1736 1999; 
  • 11 Bornstein S R, Ehrhart-Bornstein M, Scherbaum W A, Pfeiffer E F, Holst J J. Effects of splanchnic nerve stimulation on the adrenal cortex may be mediated by chromaffin cells in a paracrine manner.  Endocrinology. 127 900-906 1990; 
  • 12 Bornstein S R, Ehrhart-Bornstein M, Usadel H, Bockmann M, Scherbaum W A. Morphological evidence for a close interaction of chromaffin cells with cortical cells within the adrenal gland.  Cell Tissue Res. 265 1-9 1991; 
  • 13 Bornstein S R, Gonzalez-Hernandez J A, Ehrhart-Bornstein M, Adler G, Scherbaum W A. Intimate contact of chromaffin and cortical cells within the human adrenal gland forms the cellular basis for important intraadrenal interactions.  J Clin Endocrinol Metab. 78 225-232 1994; 
  • 14 Bornstein S R, Haidan A, Ehrhart-Bornstein M. Cellular communication in the neuro-adrenocortical axis: role of vasoactive intestinal polypeptide (VIP).  Endocr Res. 22 819-829 1996; 
  • 15 Bornstein S R, Stratakis C A, Chrousos G P. Adrenocortical tumors: recent advances in basic concepts and clinical management.  Ann Intern Med. 130(9) 759-771 1999A; 
  • 16 Bornstein S R, Tajima T, Eisenhofer G, Haidan A, Aguilera G. Adrenomedullary function is severely impaired in 21-hydroxylase-deficient mice.  FASEB J. 13(10) 1185-1194 1999B; 
  • 17 Bornstein S R, Wolkersdörfer G W, Tauchnitz R, Preas H L, Chrousos G P, Suffredini A F. Plasma dehydroepiandrosterone levels during experimental endotoxemia and anti-inflammatory therapy in humans.  Crit Care Med. 28 2103-2106 2000; 
  • 18 Brown T J, Ginz B, Oakey R E. Effects of polypeptide hormone preparations on steroid production by the human foetal adrenal gland during superfusion.  J Endocrinol. 79 60P-61P 1978; 
  • 19 Casson P R, Andersen R N, Herrod H G, Stentz F B, Straughn A B, Abraham G E, Buster J E. Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women.  Am J Obstet Gynecol. 169 1536-1539 1993; 
  • 20 Cohen H N, Wallace A M, Beastall G H, Fogelman I, Thomson J A. Clinical value of adrenal androgen measurement in the diagnosis of delayed puberty.  Lancet. 1 689-692 1981; 
  • 21 Crickard K, Ill C R, Jaffe R B. Control of proliferation of human fetal adrenal cells in vitro.  J Clin Endocrinol Metab. 53 790-796 1981; 
  • 22 Cutler G BJ, Davis S E, Johnsonbaugh R E, Loriaux D L. Dissociation of cortisol and adrenal androgen secretion in patients with secondary adrenal insufficiency.  J Clin Endocrinol Metab. 49 604-609 1979; 
  • 23 Daynes R A, Araneo B A, Ershler W B, Maloney C, Li G Z, Ryu S Y. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative.  J Immunol. 150 5219-5230 1993; 
  • 24 De Peretti E, Forest M G. Pattern of plasma dehydroepiandrosterone sulfate levels in humans from birth to adulthood: evidence for testicular production.  J Clin Endocrinol Metab. 47 572-577 1978; 
  • 25 Ehrhart-Bornstein M, Bornstein S R, Güse-Behling H, Stromeyer H G, Rasmussen T N, Scherbaum W A, Adler G, Holst J J. Sympathoadrenal regulation of adrenal androstenedione release.  Neuroendocrinology. 59 406-412 1994; 
  • 26 Ehrhart-Bornstein M, Hinson J P, Bornstein S R, Scherbaum W A, Vinson G P. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis.  Endocr Rev. 19 101-143 1998; 
  • 27 Elenkov I J, Papanicolaou D A, Wilder R L, Chrousos G P. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications.  Proc Assoc Am Physicians. 108 374-381 1996; 
  • 28 Engeland W C. Functional innervation of the adrenal cortex by the splanchnic nerve.  Horm Metab Res. 30 311-314 1998; 
  • 29 Fottner C, Engelhardt D, Weber M M. Regulation of steroidogenesis by insulin-like growth factors (IGFs) in adult human adrenocortical cells: IGF-I and, more potently, IGF-II preferentially enhance androgen biosynthesis through interaction with the IGF-I receptor and IGF-binding proteins.  J Endocrinol. 158 409-417 1998; 
  • 30 French L E, Hahne M, Viard I, Radlgruber G, Zanone R, Becker K, Muller C, Tschopp J. Fas and Fas-ligand expression in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover.  J Cell Biol. 133 335-343 1996; 
  • 31 French L E, Tschopp J. Thyroiditis and hepatitis: Fas on the road to disease.  Nature Med. 3 387-388 1997; 
  • 32 Fujieda K, Faiman C, Feyes F I, Winter J S. The control of steroidogenesis by human fetal adrenal cells in tissue culture. IV. The effect of exposure to placental steroids.  J Clin Endocrinol Metab. 54 89-94 1982; 
  • 33 Gell J S, Oh J, Rainey W E, Carr B R. Effect of estradiol on DHEAS production in the human adrenocortical cell line, H295R.  J Soc Gynecol Investig. 5 144-148 1998; 
  • 34 Genazzani A R, Facchinetti F, Petraglia F, Pintor C, Bagnoli F, Puggioni R, Corda R. Correlations between plasma levels of opioid peptides and adrenal androgens in prepuberty and puberty.  J Steroid Biochem. 19 891-895 1983; 
  • 35 Glasow A, Breidert M, Haidan A, Anderegg U, Kelly P A, Bornstein S R. Functional aspects of the effect of prolactin (PRL) on adrenal steroidogenesis and distribution of the PRL receptor in the human adrenal gland.  J Clin Endocrinol Metab. 81 3103-3111 1996; 
  • 36 Grothe C, Unsicker K. Immunocytochemical mapping of basic fibroblast growth factor in the developing and adult rat adrenal gland.  Histochemistry. 94 141-147 1990; 
  • 37 Haidan A, Hilbers U, Bornstein S R, Ehrhart-Bornstein M. Human adrenocortical NCI-H295 cells express VIP receptors. Steroidogenic effect of vasoactive intestinal peptide (VIP).  Peptides. 19 1511-1517 1998; 
  • 38 Hammond G L, Koivisto M, Kouvalainen K, Vihko R. Serum steroids and pituitary hormones in infants with particular reference to testicular activity.  J Clin Endocrinol Metab. 49 40-45 1979; 
  • 39 Hayashi Y, Hiyoshi T, Takemura T, Kurashima C, Hirokawa K. Focal lymphocytic infiltration in the adrenal cortex of the elderly: immunohistological analysis of infiltrating lymphocytes.  Clin Exp Immunol. 77 101-105 1989; 
  • 40 Heym C, Colombo-Benckmann M, Mayer B. Immunohistochemical demonstration of the synthesis enzyme for nitric oxide and of comediators in neurons and chromaffin cells of the human adrenal medulla.  Anat Anz. 176 11-16 1994; 
  • 41 Hinson J P. Paracrine control of adrenocortical function: a new role for the medulla?.  J Endocrinol. 124 7-9 1990; 
  • 42 Ho M M, Vinson G P. Endocrine control of the distribution of basic fibroblast growth factor, insulin-like growth factor-I and transforming growth factor-beta 1 mRNAs in adult rat adrenals using non-radioactive in situ hybridization.  J Endocrinol. 144 379-387 1995; 
  • 43 Holgert H, Dagerlind A, Hokfelt T. Immunohistochemical characterization of the peptidergic innervation of the rat adrenal gland.  Horm Metab Res. 30 315-322 1998; 
  • 44 Hornsby P J. The regulation of adrenocortical function by control of growth structure. In: Anderson D, Winter JSP (eds) Adrenal Cortex. Butterworths, London 1-31 1985
  • 45 Hornsby P J, O'Hare M J, Neville A M. Functional and morphological observations on rat adrenal zona glomerulosa cells in monolayer culture.  Endocrinology. 95 1240-1251 1974; 
  • 46 Ibanez L, Potau N, Marcos M V, de Zegher F. Corticotropin-releasing hormone as adrenal androgen secretagogue.  Pediatr Res. 46 351-353 1999A; 
  • 47 Ibanez L, Potau N, Marcos M V, de Zegher F. Corticotropin-releasing hormone: a potent androgen secretagogue in girls with hyperandrogenism after precocious pubarche.  J Clin Endocrinol Metab. 84 4602-4606 1999B; 
  • 48 Khorram O, Vu L, Yen S SC. Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men.  J Gerontol. 52A M1-M7 1997; 
  • 49 Kristiansen S B, Endoh A, Casson P R, Buster J E, Hornsby P J. Induction of steroidogenic enzyme genes by insulin and IGF-I in cultured adult human adrenocortical cells.  Steroids. 62 258-265 1997; 
  • 50 Kroboth P D, Salek F S, Pittenger A L, Fabian T J, Frye R F. DHEA and DHEA-S: a review.  J Clin Pharmacol. 39 327-348 1999; 
  • 51 L'Allemand D, Penhoat A, Lebrethon M C, Ardevol R, Baehr V, Oelkers W, Saez J M. Insulin-like growth factors enhance steroidogenic enzyme and corticotropin receptor messenger ribonucleic acid levels and corticotropin steroidogenic responsiveness in cultured human adrenocortical cells.  J Clin Endocrinol Metab. 81 3892-3897 1996; 
  • 52 Labrie F, Belanger A, Van L T, Labrie C, Simard J, Cusan L, Gomez J L, Candas B. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging.  Steroids. 63 322-328 1998; 
  • 53 Langlois D, Le Roy C, Penhoat A, Lebrethon M C, Saez J M. Autocrine role of TGF beta1 in adrenal.  Horm Metab Res. 30 411-415 1998; 
  • 54 Lavallee B, Provost P R, Kahwash Z, Nestler J E, Belanger A. Effect of insulin on serum levels of dehydroepiandrosterone metabolites in men.  Clin Endocrinol (Oxf). 46 93-100 1997; 
  • 55 Lebrethon M C, Jaillard C, Naville D, Begeot M, Saez J M. Regulation of corticotropin and steroidogenic enzyme mRNAs in human fetal adrenal cells by corticotropin, angiotensin-II and transforming growth factor-β1.  Mol Cell Endocrinol. 106 137-143 1994A; 
  • 56 Lebrethon M C, Jaillard C, Naville D, Begeot M, Saez J M. Effects of transforming growth factor-β1 on human adrenocortical fasciculata-reticularis cell differentiated functions.  J Clin Endocrinol Metab. 79 1033-1039 1994B; 
  • 57 Lobo R A, Goebelsmann U, Brenner P F, Mishell D RJ. The effects of estrogen on adrenal androgens in oophorectomized women.  Am J Obstet Gynecol. 142 471-478 1982; 
  • 58 Marx C, Bornstein S R, Wolkersdörfer G W, Peter M, Sippell W G, Scherbaum W A. Relevance of major histocompatibility complex class II expression as a hallmark for the cellular differentiation in the human adrenal cortex.  J Clin Endocrinol Metab. 82 3136-3140 1997; 
  • 59 Marx C, Ehrhart-Bornstein M, Scherbaum W A, Bornstein S R. Regulation of adrenocortical function by cytokines-relevance for immune-endocrine interaction.  Horm Metab Res. 300 416-420 1998A; 
  • 60 Marx C, Wolkersdörfer G W, Bornstein S R. A new view on immune-adrenal interactions: role for Fas and Fas ligand?.  Neuroimmunomodulation. 5 5-8 1998B; 
  • 61 McDonald T J, Nathanielsz P W. The involvement of innervation in the regulation of fetal adrenal steroidogenesis.  Horm Metab Res. 30 297-302 1998; 
  • 62 McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy.  Nat Med. 1 460-463 1995; 
  • 63 Mellon S H, Shively J E, Miller W L. Human proopiomelanocortin (79-96), a proposed androgen stimulatory hormone, does not affect steroidogenesis in cultured human fetal adrenal cells.  J Clin Endocrinol Metab. 72 19-22 1991; 
  • 64 Merke D P, Bornstein S R, Braddock D, Chrousos G P. Adrenal lymphocytic infiltration and adrenocortical tumors in a patient with 21-hydroxylase deficiency.  N Engl J Med. 340 1121-1122 1999; 
  • 65 Merke D P, Chrousos G P, Eisenhofer G, Weise M, Keil M F, Rogol A D, Van Wyk J J, Bornstein S R. Adrenomedullary dysplasia and hypofunction in patients with congenital adrenal hyperplasia.  N Engl J Med. 2000, in press; 
  • 66 Nestler J E, Clore J N, Strauss J F, Blackard W G. The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans.  J Clin Endocrinol Metab. 64 180-184 1987; 
  • 67 Neville A M, O'Hare M J. Histopathology of the human adrenal cortex.  Clin Endocrinol Metab. 14 791-820 1985; 
  • 68 O'Connell Y, McKenna T J, Cunningham S K. The effect of prolactin, human chorionic gonadotropin, insulin and insulin-like growth factor 1 on adrenal steroidogenesis in isolated guinea-pig adrenal cells.  J Steroid Biochem Mol Biol. 48 235-240 1994; 
  • 69 Oelkers W. Dehydroepiandrosterone for adrenal insufficiency.  N Engl J Med. 341 1073-1074 1999; 
  • 70 Orentreich N, Brind J L, Rizer R L, Vogelman J H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood.  J Clin Endocrinol Metab. 59 551-555 1984; 
  • 71 Parker C RJ, Mixon R L, Brissie R M, Grizzle W E. Aging alters zonation in the adrenal cortex of men.  J Clin Endocrinol Metab. 82 3898-3901 1997; 
  • 72 Parker C RJ, Stankovic A K, Faye-Petersen O, Falany C N, Li H, Jian M. Effects of ACTH and cytokines on dehydroepiandrosterone sulfotransferase messenger RNA in human adrenal cells.  Endocr Res. 24 669-673 1998; 
  • 73 Parker L N. Control of adrenal androgen secretion.  Endocrinol Metab Clin North Am. 20 401-421 1991; 
  • 74 Parker L N, Odell W D. Evidence for existence of cortical androgen-stimulating hormone.  Am J Physiol. 236 E616-E620 1979; 
  • 75 Parker L N, Sack J, Fisher D A, Odell W D. The adrenarche: prolactin, gonadotropins, adrenal androgens, and cortisol.  J Clin Endocrinol Metab. 46 396-401 1978; 
  • 76 Parker T L, Kesse W K, Mohamed A A, Afework M. The innervation of the mammalian adrenal gland.  J Anat. 183 265-276 1993; 
  • 77 Päth G, Bornstein S R, Ehrhart-Bornstein M, Scherbaum W A. Interleukin-6 and the interleukin-6 receptor in the human adrenal gland: expression and effects on steroidogenesis.  J Clin Endocrinol Metab. 82 2343-2349 1997; 
  • 78 Päth G, Bornstein S R, Spath-Schwalbe E, Scherbaum W A. Direct effects of interleukin-6 on human adrenal cells.  Endocr Res. 22 867-873 1996; 
  • 79 Penhoat A, Sanchez P, Jaillard C, Langlois D, Begeot M, Saez J M. Human proopiomelanocotin (79-96), a proposed cortical androgen stimulating hormone, does not affect steroidogenesis in cultured human adult adrenal cells.  J Clin Endocrinol Metab. 72 23-26 1991; 
  • 80 Polderman K H, Gooren L J, van der Veen E A. Testosterone administration increases adrenal response to adrenocorticotrophin.  Clin Endocrinol (Oxf). 40 595-601 1994; 
  • 81 Posner B I, Kelly P A, Shiu R P, Friesen H G. Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization.  Endocrinology. 95 521-531 1974; 
  • 82 Regelson W, Loria R, Kalimi M. Dehydroepiandrosterone (DHEA) the “mother steroid”. I. Immunologic action.  Ann N Y Acad Sci. 719 553-563 1994; 
  • 83 Robinson P, Baterman A, Mulay S, Spencer S J, Jaffe R B, Solomon S, Bennett H P. Isolation and characterization of three forms of joining peptide from adult pituitaries: lack of adrenal androgen stimulating activity.  Endocrinology. 129 859-867 1991; 
  • 84 Sasano H, Suzuki T, Shizawa S, Kato K, Nagura H. Transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor expression in normal and diseased human adrenal cortex by immunohistochemistry and in situ hybridization.  Mod Pathol. 7 741-746 1994; 
  • 85 Schiebinger R J, Chrousos G P, Cutler G BJ, Loriaux D L. The effect of serum prolactin on plasma adrenal androgens and the production and metabolic clearance rate of dehydroepiandrosterone sulfate in normal and hyperprolactinemic subjects.  J Clin Endocrinol Metab. 62 202-209 1986; 
  • 86 Smith R, Mesiano S, Chan E C, Brown S, Jaffe R B. Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells.  J Clin Endocrinol Metab. 83 2916-2920 1998; 
  • 87 Sobrinho L G, Kase N G, Grunt J A. Changes in adrenocortisol function of patients with gonadal dysgenesis after treatment with estrogen.  J Clin Endocrinol Metab. 33 110-114 1971; 
  • 88 Spencer N F, Norton S D, Harrison L L, Li G Z, Daynes R A. Dysregulation of IL-10 production with aging: possible linkage to the age-associated decline in DHEA and its sulfated derivative.  Exp Gerontol. 31 393-408 1996; 
  • 89 Stankovic A K, Dion L D, Parker C R. Effects of transforming growth factor-beta on human fetal adrenal steroid production.  Mol Cell Endocrinol. 99 145-151 1994; 
  • 90 Stocco D M, Clark B J. Regulation of the acute production of steroids in steroidogenic cells.  Endocr Rev. 17 221-244 1996; 
  • 91 Straub R H, Konecna L, Hrach S, Rothe G, Kreutz M, Scholmerich J, Falk W, Lang B. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence.  J Clin Endocrinol Metab. 83 2012-2017 1998; 
  • 92 Suda T, Tomori N, Tozawa F, Demura H, Shizume K, Mouri T, Mirura Y, Sasano N. Immunoreactive corticotropin and corticotropin-releasing factor in human hypothalamus, adrenal, lung cancer and pheochromocytoma.  J Clin Endocrinol Metab. 58 919-924 1984A; 
  • 93 Suda T, Tomori N, Tozawa F, Mouri T, Demura H, Shizume K. Distribution and characterization of immunoreactive corticotropin-releasing factor in human tissues.  J Clin Endocrinol Metab. 59 861-866 1984B; 
  • 94 Toth I E, Hinson J P. Neuropeptides in the adrenal gland: distribution, localization of receptors, and effects on steroid hormone synthesis.  Endocr Res. 21 39-51 1995; 
  • 95 Vermeulen A. Adrenal androgens and aging. In: Genazzani AR, Thijssen JHH, Siiteri PK (eds) Adrenal Androgens Raven, New York 207-217 1980
  • 96 Vermeulen A. Decreased androgen levels and obesity in men.  Ann Med. 28 13-15 1996; 
  • 97 Vinson G P, Hinson J P, Toth I E. The neuroendocrinology of the adrenal cortex.  J Neuroendocrinol. 6 235-246 1994; 
  • 98 Willenberg H S, Bornstein S R, Hiroi N, Path G, Goretzki P E, Scherbaum W A, Chrousos G P. Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function.  Mol Psychiatry. 5 137-141 2000; 
  • 99 Willenberg H S, Stratakis C A, Marx C, Ehrhart-Bornstein M, Chrousos G P, Bornstein S R. Aberrant interleukin-1 receptors in a cortisol-secreting adrenal adenoma causing Cushing's syndrome.  N Engl J Med. 339 27-31 1998; 
  • 100 Wolkersdörfer G W, Lohmann T, Marx C, Schroder S, Pfeiffer R, Stahl H D, Scherbaum W A, Chrousos G P, Bornstein S R. Lymphocytes stimulate dehydroepiandrosterone production through direct cellular contact with adrenal zona reticularis cells: a novel mechanism of immune-endocrine interaction.  J Clin Endocrinol Metab. 84 4220-4227 1999; 

Salvatore AlesciMD 

PREB/NICHD/NIH

Bldg 10, Room 10N242

10 Center drive, MSC1583

Bethesda, MD 20892-1583

USA

Telefon: + 301-496-0610/0542

Fax: + 301-402-7572

eMail: alescis@mail.nih.gov

    >